key: cord-0313802-4n4dlwpm
authors: Tayler, A.; Ashworth, H.; Bou Saba, G.; Wadhwa, H.; Dundek, M.; Ng, E.; Opondo, K.; Mkony, M.; Moshiro, R.; Burke, T.
title: Feasibility of a Novel Ultra-Low-Cost Bubble CPAP (bCPAP) System for Neonatal Respiratory Support at Muhimbili National Hospital, Tanzania
date: 2022-05-17
journal: nan
DOI: 10.1101/2022.05.16.22275176
sha: 87e1ddee6ddae0117291dc1a094d10a1c57bec6a
doc_id: 313802
cord_uid: 4n4dlwpm

Objective Continuous Positive Airway Pressure (CPAP) is recommended in the treatment of respiratory distress syndrome of premature newborns, however there are significant barriers to its implementation in low resource settings. The objective of this study was to evaluate the feasibility of use and integration of Vayu bCPAP Systems into the newborn unit at Muhimbili National Hospital in Tanzania. Study Design A Mixed Methods study was conducted from April 6 to October 6 2021. Demographic and clinical characteristics of patients treated with Vayu bCPAP Systems were collected and analyzed. Healthcare workers were interviewed until thematic saturation. Interviews were transcribed, coded, and analyzed using a framework analysis. Results 370 patients were treated with Vayu bCPAP Systems during the study period. Mean birth weight was 1522 g (500-3800), mean duration of bCPAP treatment was 7.2 days (<1- 39 d), and survival to wean was 81.4%. Twenty-four healthcare workers were interviewed and perceived Vayu bCPAP Systems as having become essential for treating neonatal respiratory distress at MNH. Key reasons were that Vayu bCPAP Systems improve patient outcomes, are easy to use, and more patients are now able to receive quality care. Barriers to integration included durability of oxygen tubing material and training. Conclusions It was feasible to implement and integrate Vayu bCPAP Systems into the care of neonates at Muhimbili National Hospital.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

System does not require electricity or compressed air and was granted regulatory approval in a number of countries, including US FDA Emergency Use Authorization, Kenya, and Tanzania.

The purpose of this study was to evaluate the feasibility of implementation and use of Vayu bCPAP Systems in the Newborn Unit at Muhimbili National Hospital in Tanzania. Lessons from this study may inform improvements in device design, implementation, and strategies for scale.

Muhimbili National Hospital-Upanga (MNH) is located in Dar es Salaam Tanzania, is the largest referral hospital in the country, has 1,500 inpatient beds, and admits 1,000 to 1,200 inpatients weekly. The National Hospital serves the general public, which includes the more than six million inhabitants of Dar es Salaam plus the neighboring regions.

The "Newborn Unit" is located on the second floor of the maternity bloc and includes Wards 36 and 37. In 2021, the Newborn Unit admitted an average of 471 neonates per month, with an overall mortality rate of 9.1%. Ward 36 houses stable but sick term newborns and Ward 37 houses neonates that require higher levels of care, including premature babies. Ward 37 is further subdivided into a Neonatal Intensive Care Unit (NICU), High-Dependency Unit (HDU), and stepdown ward. During the study period 30 Vayu, seven Diamedica, and three Fanem bCPAP devices were functioning and available for use across the Newborn Unit. Additionally, four Drager Babylog 8000 mechanical ventilators had CPAP capabilities. Previously procured Pumani and MTTS bCPAP devices were inoperable.

Vayu bCPAP Systems were introduced to the MNH Newborn Unit in January 2020 over five days using a standardized training package that included training four master trainers. A two-day refresher course was conducted in February 2021. The training program reviewed device assembly, application, monitoring, troubleshooting, and reprocessing. No clinical training was provided and clinicians were free to select which CPAP device to use on their patients. A WhatsApp group was used to respond to master trainer questions. Master trainers conducted training sessions for all staff that cared for neonates.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 17, 2022. ;  https://doi.org/10.1101/2022.05. 16 .22275176 doi: medRxiv preprint

From April 8, 2021 to October 10, 2021 , clinical characteristics of patients that received CPAP therapy in the MNH Newborn Unit were prospectively recorded. The data collected included date and time of birth, admission date, APGAR scores at one and five minutes of life, estimated gestational age, sex, birth weight, recorded diagnosis, type/brand of CPAP device used, and date and time of CPAP therapy initiation. Survival to being fully weaned off CPAP was added as an indicator on June 4 th . Variables were collected by dedicated nurse research coordinators. The research teams at MNH and the Vayu Global Health Foundation met weekly via Zoom to review data. Standard descriptive analyses (mean, median, and ranges) of the clinical characteristics were performed using Microsoft Excel (Microsoft, Redmond, WA, USA).

An interview guide was developed in an iterative fashion. Two researchers trained in qualitative methods (AT, HA) conducted semi-structured interviews (appendix 1) at MNH from August 23 rd to September 2 nd , 2021. Purposive sampling of health providers was employed to obtain perspectives from a variety of cadres. Healthcare workers with at least six months of experience using CPAP for neonates at MNH were individually interviewed. Consent was obtained orally and in writing after each respondent was informed of study standards and protocol. A translator was present during interviews to translate between Swahili and English if requested by the participant or researcher. Interviews were conducted face-to-face in a private room at the hospital and continued until thematic saturation. Framework analysis was employed to identify themes and construct an initial codebook. Four interviews were used to test and revise the codebook. The final codebook was applied to all interviews. Data were transcribed, coded, and analyzed using NVivo (QSR International Pty Ltd. 2020). Inter-rater reliability of the coders was assessed using a Kappa coefficient.

Ethical approval was obtained from MNH Institution Review Board and the Tanzania National . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) (1) an external pressurized oxygen source (2) a Venturi blender (3) two bacterial viral filters, one on inspiratory and one on expiratory limb (4) humidifier (5) nasal prongs (6) pressure generator with an adjustable wand and (7) Systems. Of the neonates placed on Vayu bCPAP Systems, 59.7% were inborn while the rest were either transferred from an outside facility or transported to MNH after home birth. The most common diagnosis of neonates treated with Vayu bCPAP system was RDS (88.9%) (table 1) . Data collection was refined on June 4 th and over the following four months, 179 (81.4%) of the 220 infants placed on Vayu bCPAP devices survived to weaning (table 2). Neonates with higher birth weights were more likely to survive. There was no difference in time to wean between neonates who were inborn (n=221) and outborn (n=149). Inborn neonates trended toward a slightly higher survival to wean rate (82.5%) than their outborn counterparts (79.5%).

Twenty-four in-depth interviews were completed, including 14 (58%) nurses, five (21%) consultant pediatricians, four nursing assistants (17%), and one (4%) bioengineer. The nursing assistants cleaned the devices and helped nurses with patient care while the bioengineer repaired and maintained CPAP devices. Fifteen (62.5%) of the interviewees were women and nine (37.5%) were men. The average experience of the interviewees working with neonates was 2.9 years (10 months to 11 years).

The key themes that emerged from the interviews included usability of Vayu bCPAP Systems, treatment outcomes, and integration into hospital systems and delivery of care. There was substantial agreement (κ = 0.71) between the four coders.

All clinician respondents (16 nurses and 3 consultant pediatricians) believed there has been a reduction in morbidity and mortality from respiratory illness in the MNH Newborn Unit because of the Vayu bCPAP Systems. Respondents stated that Vayu bCPAP Systems improved outcomes primarily by decreasing RDS progression and severity. It was described that Vayu bCPAP devices can be rapidly applied and that newborns now spend less time in intensive care for RDS.

Respondents universally agreed that complications associated with Vayu bCPAP Systems were comparable to other devices. One nurse reflected on his experiences treating patients with Vayu bCPAP Systems:

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) Another nurse from the MNH NICU and HDU described her experience with Vayu bCPAP Systems: "The patients get a lot of benefits. The babies achieve improvement from their previous . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 17, 2022 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 17, 2022. believe with the use of CPAP, especially in Room 2, most of the CPAP are Vayu CPAP.

Clinicians were asked to discuss whether patients sustained negative effects while being treated with Vayu bCPAP Systems. When asked about complications associated with use of Vayu bCPAP Systems some nurses reported occasional nasal septal injury. Respondents associated complications with nasal prongs not being secured properly. All clinicians emphasized that rates of septal injuries with Vayu bCPAP Systems were similar to, or lower than other CPAP devices.

When asked about the rates of septal trauma, one nurse stated, "So that piece [Vayu bCPAP nasal prongs] is soft and that cannot corrode the septum. But the RAM cannula is different; it is a simple [part] in MTTS to apply and secure. But there is great risk [with RAM cannula] for corroding the septum." Respondents further clarified that the RAM cannula was easier to apply since it is secured by a cinch around the patient's head, compared to the Vayu bCPAP that relies on the hook-andloop fastener mustache and hat (Fig 1B) .

Respondents unanimously agreed on the simplicity and ease of operation of Vayu bCPAP Systems.

When discussing the device interface, a consultant pediatrician noted, "… It's easy to use for anyone. You can even teach a first-term intern to use this, then they will use it." Attributes of the Vayu bCPAP Systems that were viewed by respondents favorably were: easy assembly, easy monitoring, and minimal resource requirements.

18 of 19 clinician respondents described the assembly of a Vayu bCPAP device as easy.

Respondents who used Vayu bCPAP Systems reported the devices' design as having few parts and being more easily assembled than other CPAP devices. A consultant pediatrician stated that assembly of Vayu bCPAP devices was easy:

When you see the patient who usually needs the Vayu, you would connect them to the oxygen first while prepping. You take maybe five minutes to pull up the tubes from there . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 

All respondents believed that usability of CPAP devices was related to their ability to support quality treatment. The most common barrier to use of Vayu bCPAP Systems was that after several cleaning and use cycles the oxygen tubing (Fig 1B) . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 17, 2022. ; https://doi.org/10.1101/2022.05.16.22275176 doi: medRxiv preprint

Three of the four nursing assistants responsible for cleaning CPAP devices considered Vayu bCPAP devices more challenging to clean than Diamedica CPAP devices. They described that the corrugated breathing and humidifier tubes from Vayu devices require extra water to fully rinse out the soap and more time is necessary for drying. One nursing assistant stated that the cleaning process for one Vayu bCPAP device takes up to 15 minutes to complete. Another described challenge was in ensuring the blender was fully cleaned. Unlike the other reusable components of the Vayu bCPAP System, the oxygen blender is not immersed in reprocessing solutions but instead manually wiped clean with medical grade alcohol. All nursing assistants demonstrated familiarity with the cleaning procedure of the blender, but two expressed that they were not certain they were completely clearing the blender of dirt and other debris.

Healthcare workers were asked to describe how bCPAP devices were integrated into clinical care at MNH. Staff reported that Vayu bCPAP Systems improved their care routine since their introduction into the Newborn Unit. One pediatrician said that Vayu bCPAP Systems positively altered the hospital landscape by increasing the number of accessible CPAP devices. She described that she, her fellow clinicians, and their patients have benefited since their introduction and integration:

In treatment of RDS, CPAP is a major goal. So Vayu bCPAP Systems have allowed clinicians to task-shift device monitoring and bCPAP treatment initiation, and to be more efficient in providing care. For example, in the MNH Newborn Unit, cots are situated along perimeter walls, allowing pediatricians and nurses to quickly assess . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 17, 2022 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 17, 2022. ; https://doi.org/10.1101/2022.05.16.22275176 doi: medRxiv preprint A nurse with two years of experience in the Newborn Unit discussed the change in clinical routine prior to and after incorporating Vayu devices: "We save the lives of a lot of babies by using the Vayu CPAP. And I think this one -I think we started with the Diamedica, and then the Fanem, before we started to use this Vayu. But after the introduction of Vayu, we started to use the Vayu device." The same nurse went on to describe her satisfaction with Vayu bCPAP Systems from a personal perspective: "Who benefits much more is the caregiver. Yes, the caregiver. I think it's easy to operate. And sometimes it's like we said before -it's easy to find, 'Where is the fault, where is the problem?' I think the caregiver benefits much more because it's easy to use."

Clinical providers described that it is a great advantage that Vayu bCPAP Systems are able to operate while under or attached to cots and that this played an important role in integration of the devices into care. A nurse in Ward 37 highlighted this:

What is bad about taking up space? It's because we have many neonates, we have a lot of cots, so we need space. So if you want to provide CPAP to a newborn who is between other two cots, you don't have the space for it to fit and then continue providing.

Since Vayu bCPAP Systems can be affixed to the side or underneath a cot, respondents felt this was great help to their lack of space. A nurse working primarily in NICU/HDU stated: "While this one [Vayu] we put under the bed, other ones need space, and you can't. When there is not enough space, you cannot apply the machine."

Respondents described that with as many as 300 newborns in the Newborn Unit during high-birth season, the ability to transport, apply, and monitor Vayu bCPAP Systems easily was extremely helpful. Vayu bCPAP devices were described by respondents as lightweight and portable. Four respondents reported transporting patients on Vayu devices to different buildings or wards by using portable pressurized oxygen tanks. Other CPAP devices in the Newborn Unit at MNH are not able to be utilized flexibly due to their size, weight, and dependence on electricity. A nurse assigned to Ward 37 described portability as a feature unique to Vayu bCPAP devices, which influenced her decision to incorporate them into her routine care for sick preterm NICU, and HDU patients: "If we have portable oxygen, we can use Vayu CPAP. As compared to others, which cannot be used at all." . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 17, 2022 

The bioengineer expressed concern about hospital-acquired infections associated with increased patient volumes in the newborn unit during the COVID-19 pandemic when using bCPAP devices without expiratory limb filters. He described that the expiratory limb filters in Vayu bCPAP Systems are especially important in their crowded setting. 

Vayu bCPAP Systems were found to be feasible for use at MNH across all cadres. The most common findings included strong associations with ease of use, improved treatment and patient outcomes, and excellent integration into the system of care delivery. The technical simplicity and durability of Vayu bCPAP Systems were the main reasons the devices were said to be ideal for the MNH setting. Portability, compactness, and lack of need for electricity and maintenance influenced the high level of satisfaction. An additional critical attribute of Vayu bCPAP Systems was that devices could rapidly be assembled and brought to the bedside, and early treatment initiated.

Some studies have described significant barriers to implementation of CPAP devices in LMICs. (18) (19) (20) (21) (22) (23) (24) In our study Vayu bCPAP Systems were found to be easy to use across all cadres, appropriate for the MNH setting, and able to be successfully integrated into the Newborn Unit.

This ease of use and system integration allowed for task shifting whereby nurses initiated treatment without waiting for an attending pediatrician. The task shifting that occurred after introduction of Vayu bCPAP Systems is consistent with similar findings in other low-resource settings after implementation of simple CPAP devices. (14, 25) A concern with the Vayu bCPAP Systems was occasional disconnection of the oxygen tubing from the blender at FiO2s greater than .60. (17) Upon further investigation it was found that oxygen tubing ( Figure 1A ) that had been reprocessed many times (distinguishable by exterior hardening/yellowing) became vulnerable to disconnection at higher FiO2s. Hose clamps were introduced as an interim measure to secure older oxygen tubing, and subsequently the material of the oxygen tubing was modified to increase the hardness (from ASTM D 2240 Shore A 70 hardness to 80 hardness). The breathing and humidifier tubes were also updated to remove the corrugation that made devices more challenging to clean. Lastly, the blender material was also modified so . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 17, 2022. ; https://doi.org/10.1101/2022.05.16.22275176 doi: medRxiv preprint that it can be submerged and cleaned as easily as the other device components in reprocessing solution.

While our study demonstrated that it is feasible to treat neonates with Vayu bCPAP Systems, a few prior studies found that introduction of commercial CPAP devices alone did not improve outcomes in low resource settings. (23, 24, 26) Further research is necessary to identify approaches to introduction and integration of Vayu bCPAP Systems to optimize quality care and patient outcomes across various settings.

This study contributes to the growing evidence supporting the use of CPAP devices that are designed for low resource settings and include an implementation package. A holistic implementation package is critical for sustained uptake into local settings. (8, 14, 15) The successful integration of Vayu bCPAP devices into the national hospital of Tanzania may be an example for other referral hospitals in the region.

This study assessed feasibility of implementation, use and integration of Vayu bCPAP Systems and did not attempt to study effectiveness. It was not the goal of this study to quantify the clinical impact of Vayu bCPAP Systems, but rather to understand if the device is feasible for use at MNH.

While MNH is a national referral hospital and some of the findings may not be generalizable to other settings, the ease of use among all levels of providers is promising.

Survival to wean was only reported for the latter 220 (59.5%) consecutive neonates because this specific indicator was not recorded until eight weeks after study launch. However, over the 6 months of this study there were no significant changes in neonatal care, staff training or clinical protocols, or patient characteristics. Due to the limited number of mechanical ventilators (4 Drager Babylog devices) at MNH, many neonates that met criteria for mechanical ventilation were treated with CPAP because no mechanical ventilators were available. These neonates were included in our study population and likely negatively impacted the survival to wean data.

Purposive sampling to thematic saturation was employed to include diverse perspectives, however this method may have introduced selection bias. Additionally, social desirability bias could have affected respondents' answers.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 17, 2022. ; https://doi.org/10.1101/2022.05.16.22275176 doi: medRxiv preprint CONCLUSION It is feasible to use Vayu bCPAP Systems at Muhimbili National Hospital. Easy device operation, low resource utilization, and low maintenance requirements were critical factors for integration. (8, 14, 15) Future research should study feasibility of use of Vayu bCPAP Systems in lower level facilities and transport settings, and identify attributes that optimize outcomes. (30) 

Newborns: reducing mortality. World Health Organization

Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the Sustainable Development Goals

Neonatal Respiratory Distress Syndrome: Tackling A Worldwide Problem

National, regional, and global levels and trends in neonatal mortality between 1990 and 2017, with scenario-based projections to 2030: a systematic analysis. The Lancet Global Health

Neonatal mortality from respiratory distress syndrome: lessons for low-resource countries

Bubble CPAP -A primary respiratory support for respiratory distress syndrome in newborns

World Health Organization. WHO recommendation on continuous positive airway pressure therapy for the treatment of preterm newborns with respiratory distress syndrome. Geneva: WHO Reproductive Health Library

Experiences with implementation of continuous positive airway pressure for neonates and infants in low-resource settings: A scoping review

Reducing preterm mortality in eastern Uganda: the impact of introducing low-cost bubble CPAP on neonates <1500 g

Effect of Treatment of Premature Infants with Respiratory Distress Using Low-cost Bubble CPAP in a Rural African Hospital

Efficacy and safety of CPAP in low-and middle-income countries

Risk and benefits of Bubble Continuous Positive Airway Pressure for neonatal and childhood respiratory diseases in Low-and Middle-Income countries

To Bubble or Not? A Systematic Review of Bubble Continuous Positive Airway Pressure in Children in Low-and Middle-Income Countries

Efficacy and safety of bubble CPAP in neonatal care in low and middle income countries: a systematic review

Barriers and facilitators to implementing bubble CPAP to improve neonatal health in sub-Saharan Africa: a systematic review

Special Edition: Progress Towards the Sustainable Development Goals

Evaluation of a Bubble CPAP System for Low Resource Settings. Respir Care

A new low-cost commercial bubble CPAP (bCPAP) machine compared with a traditional bCPAP device in Nigeria. Paediatrics & international Child Health

Healthcare workers' views on the use of continuous positive airway pressure (CPAP) in neonates: a qualitative study in Andhra Pradesh

Is continuous positive airway pressure a feasible treatment modality for neonates with respiratory distress syndrome in a rural district hospital

Neonatal CPAP for Respiratory Distress Across Malawi and Mortality

Bubble CPAP and oxygen for child pneumonia care in Malawi: a CPAP IMPACT time motion study

Bubble continuous positive airway pressure for children with high-risk conditions and severe pneumonia in Malawi: an open label, randomised, controlled trial

Bubble CPAP in resource-poor settings: friend or foe?

An evaluation of bubble-CPAP in a neonatal unit in a developing country: effective respiratory support that can be applied by nurses

CPAP and high-flow oxygen to address high mortality of very severe pneumonia in low-income countries -keeping it in perspective. Paediatr Int Child Health

Neonatal CPAP for Respiratory Distress Across Malawi and Mortality

Aftermath of a clinical trial: evaluating the sustainability of a medical device intervention in Ghana

Using a peer mentorship approach improved the use of neonatal continuous positive airway pressure and related outcomes in Malawi

Critical Breaths in Transit: A Review of Noninvasive Ventilation (NIV) for Neonatal and Pediatric Patients During Transportation. Front Pediatr

Neonatal Survival in Sub-Sahara: A Review of Kenya and South Africa

Neonatal death in low-to middle-income countries: a global network study

Brantuo NABarriers to decolonising educational partnerships in global healthBMJ